Hong Kong Innovative Drug Stocks Extend Declines in Afternoon Trading, Simcere Pharmaceutical Plunges Over 11%
2025-06-17 / Read about 0 minute
Author:小编   

The innovative drug sector of Hong Kong stocks extended its decline into the afternoon session. By the close of trading, Simcere Pharmaceutical had suffered a significant drop of over 11%, while Luye Pharma witnessed a decline of more than 10%. Additionally, Zai Lab and CSPC Pharmaceutical Group recorded falls of over 7% and 6%, respectively.

  • C114 Communication Network
  • Communication Home